MedPath

Assessment of the therapeutic effect of oral propranolol on retinochoroidal hemangioma

Not Applicable
Conditions
retinochoroidal hemangioma
Registration Number
JPRN-UMIN000006623
Lead Sponsor
ational Hospital Organization Nagoya Medical Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
12
Inclusion Criteria

Not provided

Exclusion Criteria

patients ineligible for oral propranolol therapy or considered ineligible for this clinical trial by investigators

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
visual acuity, size of retinochoroidal hemangioma
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath